Literature DB >> 10677408

Patients with uncomplicated coronary artery disease have reduced heart rate variability mainly affecting vagal tone.

B Wennerblom1, L Lurje, H Tygesen, R Vahisalo, A Hjalmarson.   

Abstract

AIM: To investigate whether uncomplicated chronic coronary artery disease causes changes in heart rate variability and if so, whether the heart rate variability pattern is different from that described in patients with acute myocardial infarction.
METHODS: Heart rate variability was studied in 65 patients with angina who had no previous myocardial infarcts, no other diseases, and were on no drug that could influence the sinus node. Results were compared with 33 age matched healthy subjects. The diagnosis of coronary artery disease in angina patients was established by coronary angiography in 58, by thallium scintigraphy in six, and by exercise test only in one. Patients and controls were Holter monitored 24 hours outside hospital, and heart rate variability was calculated in the frequency domain as global power (GP: 0.01-1.00 Hz), low frequency peak (LF: 0. 04-0.15 Hz), high frequency peak (HF: 0.15-0.40 Hz), LF/HF in ms(2), and in the time domain as SDNN (SD of normal RR intervals), SDANN (SD of all five minute mean normal RR intervals), SD (mean of all five minute SDs of mean RR intervals), rMSSD (root mean square of differences of successive normal RR intervals) (all in ms), and pNN50 (proportion of adjacent normal RR intervals differing more than 50 ms from the preceding RR interval) as per cent.
RESULTS: The mean age in patients and controls was 60.4 (range 32-81) and 59.1 (32-77) years, respectively (NS), the male/female ratio, 57/65 and 24/33 (NS), and the mean time of Holter monitoring, 23.0 (18-24) and 22.8 (18-24) hours (NS). Mortality in angina patients was 0% (0/65) at one year, 0% (0/56) at two years, and 3% (1/33) at three years. Compared with healthy subjects angina patients showed a reduction in GP (p = 0.007), HF (p = 0.02), LF (p = 0.02), SD (p = 0.02), rMSSD (p = 0.01), and pNN50 (p = 0.01). No significant difference was found in RR, LF/HF, SDNN, or SDANN.
CONCLUSIONS: Uncomplicated coronary artery disease without previous acute myocardial infarction was associated with reduced high and low frequency heart rate variability, including vagal tone. SDANN and SDNN, expressing ultra low and very low frequencies which are known to reflect prognosis after acute myocardial infarction, were less affected. This is in agreement with the good prognosis in uncomplicated angina in this study.

Entities:  

Mesh:

Year:  2000        PMID: 10677408      PMCID: PMC1729341          DOI: 10.1136/heart.83.3.290

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  18 in total

1.  Heart rate variability in relation to prognosis after myocardial infarction: selection of optimal processing techniques.

Authors:  M Malik; T Farrell; T Cripps; A J Camm
Journal:  Eur Heart J       Date:  1989-12       Impact factor: 29.983

2.  Correlation of heart rate variability with clinical and angiographic variables and late mortality after coronary angiography.

Authors:  M W Rich; J S Saini; R E Kleiger; R M Carney; A teVelde; K E Freedland
Journal:  Am J Cardiol       Date:  1988-10-01       Impact factor: 2.778

3.  Impaired vagal heart rate control in coronary artery disease.

Authors:  K E Airaksinen; M J Ikäheimo; M K Linnaluoto; M Niemelä; J T Takkunen
Journal:  Br Heart J       Date:  1987-12

4.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Authors:  R E Kleiger; J P Miller; J T Bigger; A J Moss
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

5.  Assessment of autonomic function in humans by heart rate spectral analysis.

Authors:  B Pomeranz; R J Macaulay; M A Caudill; I Kutz; D Adam; D Gordon; K M Kilborn; A C Barger; D C Shannon; R J Cohen
Journal:  Am J Physiol       Date:  1985-01

6.  Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control.

Authors:  S Akselrod; D Gordon; F A Ubel; D C Shannon; A C Berger; R J Cohen
Journal:  Science       Date:  1981-07-10       Impact factor: 47.728

7.  Autonomic nervous system and malignant cardiac arrhythmias.

Authors:  R L Verrier; B Lown
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1981

8.  Neural activity and ventricular fibrillation.

Authors:  B Lown; R L Verrier
Journal:  N Engl J Med       Date:  1976-05-20       Impact factor: 91.245

9.  Role of the nervous system in experimentally induced arrhythmias.

Authors:  R A Gillis; P B Corr; D G Pace; D E Evans; J DiMicco; D L Pearle
Journal:  Cardiology       Date:  1976       Impact factor: 1.869

10.  Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog.

Authors:  M Pagani; F Lombardi; S Guzzetti; O Rimoldi; R Furlan; P Pizzinelli; G Sandrone; G Malfatto; S Dell'Orto; E Piccaluga
Journal:  Circ Res       Date:  1986-08       Impact factor: 17.367

View more
  9 in total

1.  Changes in autonomic variables following two meditative states described in yoga texts.

Authors:  Shirley Telles; Bhat Ramachandra Raghavendra; Kalkuni Visweswaraiah Naveen; Nandi Krishnamurthy Manjunath; Sanjay Kumar; Pailoor Subramanya
Journal:  J Altern Complement Med       Date:  2012-09-04       Impact factor: 2.579

Review 2.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

3.  Heart rate variability associates with asymptomatic coronary atherosclerosis.

Authors:  Sakari Simula; Esko Vanninen; Seppo Lehto; Antti Hedman; Pia Pajunen; Mikko Syvänne; Juha Hartikainen
Journal:  Clin Auton Res       Date:  2013-11-30       Impact factor: 4.435

4.  The effects of clinical and angiographic aspects of coronary artery disease on the cardiac autonomic function: a single-center prospective cohort study.

Authors:  Mahmoud Abdelnabi; Moataz Zaki; Mohamed Sadaka; Moustafa Nawar
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15

5.  Relationships between pulse wave velocity and heart rate variability in healthy men with a range of moderate-to-vigorous physical activity levels.

Authors:  G M Perkins; A Owen; I L Swaine; J D Wiles
Journal:  Eur J Appl Physiol       Date:  2006-09-30       Impact factor: 3.346

6.  Blood pressure and heart rate variability during yoga-based alternate nostril breathing practice and breath awareness.

Authors:  Shirley Telles; Sachin Kumar Sharma; Acharya Balkrishna
Journal:  Med Sci Monit Basic Res       Date:  2014-11-19

7.  Altered heart rate variability depend on the characteristics of coronary lesions in stable angina pectoris.

Authors:  Jun Feng; Ailing Wang; Chao Gao; Jing Zhang; Zhengfei Chen; Linlin Hou; Chunmiao Luo; Yongjing Jiang; Jianyuan Pan
Journal:  Anatol J Cardiol       Date:  2014-07-17       Impact factor: 1.596

8.  Sensitivity, specificity and predictive values of linear and nonlinear indices of heart rate variability in stable angina patients.

Authors:  Flávio Correa Pivatelli; Marcio Antonio Dos Santos; Gislaine Buzzini Fernandes; Marcio Gatti; Luiz Carlos de Abreu; Vitor E Valenti; Luiz Carlos M Vanderlei; Celso Ferreira; Fernando Adami; Tatiana Dias de Carvalho; Carlos Bandeira de Mello Monteiro; Moacir Fernandes de Godoy
Journal:  Int Arch Med       Date:  2012-10-30

9.  Heart Rate Variability Is Associated with Exercise Capacity in Patients with Cardiac Syndrome X.

Authors:  Dai-Yin Lu; Albert C Yang; Hao-Min Cheng; Tse-Min Lu; Wen-Chung Yu; Chen-Huan Chen; Shih-Hsien Sung
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.